[Brain metastases in pulmonary adenocarcinoma with EGFR mutation: how important is therapy with erlotinib compared to radiotherapy?]

Strahlenther Onkol. 2015 Feb;191(2):205-7. doi: 10.1007/s00066-014-0772-4.
[Article in German]
No abstract available

Publication types

  • Comment

MeSH terms

  • Adenocarcinoma / secondary*
  • Adenocarcinoma / therapy*
  • Brain Neoplasms / secondary*
  • Brain Neoplasms / therapy*
  • ErbB Receptors / genetics*
  • Female
  • Humans
  • Lung Neoplasms / pathology*
  • Male
  • Protein Kinase Inhibitors / therapeutic use*
  • Quinazolines / therapeutic use*

Substances

  • Protein Kinase Inhibitors
  • Quinazolines
  • ErbB Receptors